CorMedix (CRMD) Preferred Shares (2013 - 2025)

CorMedix has disclosed Preferred Shares across 12 years of filings, most recently posting $92.0 for Q3 2025.

• Preferred Shares for Q3 2025 came in at $92.0, down 49.45% year-over-year; the trailing twelve-month figure through Sep 2025 was $92.0 (down 49.45% YoY), and the FY2024 annual result was $137.0, down 24.73% from the prior year.
• Preferred Shares came in at $92.0 for Q3 2025 at CorMedix, roughly flat from $92.0 in the prior quarter.
• In the past five years, Preferred Shares ranged from a high of $182.0 in Q1 2021 to a low of $92.0 in Q1 2025.
• The 5-year median for Preferred Shares is $182.0 (2021), against an average of $165.42.
• Across the five-year window, Preferred Shares changed 0.0% in 2022 and sank 49.45% in 2025, its largest moves.
• CorMedix's Preferred Shares stood at $182.0 in 2021, then changed by 0.0% to $182.0 in 2022, then changed by 0.0% to $182.0 in 2023, then declined by 24.73% to $137.0 in 2024, then slumped by 32.85% to $92.0 in 2025.
• The last three Preferred Shares figures came in at $92.0 (Q3 2025), $92.0 (Q2 2025), and $92.0 (Q1 2025), per Business Quant data.